Tested under dermatological control.
Medical device
Soothes - Repairs - Treats eczema lesions
A medical device that treats and limits the recurrence of atopic, contact and chronic eczema lesions.
DEXYANE MeD Soothing repair cream is a medical device* that treats and limits the recurrence of atopic, contact and chronic eczema lesions.
DEXYANE MeD Soothing repair cream can be used as a stand-alone treatment, in combination with, or as a follow-up to topical corticosteroids to treat and limit the recurrence of eczema lesions.
• USE alone, in combination or in conjunction with topical corticosteroids
• PROTECTS the skin thanks to its pleasant texture which forms a semi-occlusive film on the surface
*DEXYANE MeD Soothing repair cream is a class CE medical device. Carefully read the instruction leaflet provided. Do not use if pregnant or breastfeeding. Do not use on the mucous membranes or on the nappy area of children still in nappies. Avoid all direct contact with eyes. Ages 3 months and up. Manufacturer: Pierre Fabre Medical Devices.
• Apply directly to inflammatory eczema lesions
• Use on its own or in combination with topical corticosteroids
Precautions to use :
• Do not use if you are allergic to any of the ingredients
• If you experience an allergic reaction consult a doctor
• Avoid contact with the eyes to prevent irritation
• In case of contact with eyes, rinse immediately with clean water
• If eye irritation persists seek medical attention
• Do not use if pregnant or breastfeeding
• Keep out of the reach of children
• Do not use on the nappy area of children still in nappies or on mucous membranes
• Do not exceed 30% of the body's surface
• Close the tube tightly after use
• If you experience any side effects as a result of using the product, seek medical advice
• Relieves itching and reduces the intensity of inflammatory signs.
• Significant improvement in the clinical signs after 3 days of applying DEXYANE MeD in combination with topical corticosteroids¹.
¹Result of a comparative clinical study conducted on 54 adults aged 18-63 with moderate to severe atopic dermatitis on the arms or behind the knees. Product applied twice a day in combination with a topical corticosteroid, versus a corticosteroid alone, for 10 days, with clinical scoring from 0 to 18 after 3 days of application. Various clinical signs included, such as pruritus. PFDC study RV442A2013147-V1-04/03/2016; 91-92.
